In the news report appeared on April 12, 2011 in Pharmabiz, it  was mentioned that a product called Biodipin-AT tablets manufactured by GSK Pharmaceuticals is also one found to have low standard quality by Maharashtra FDA in March, 2011.

GlaxoSmithKline Pharmaceuticals Ltd clarifies that it has no connection with GSK Pharmaceuticals. The company also says that it does not make any product called Biodipin-AT and none of its products have been declared as sub standard in March 2011 by FDA Maharashtra.

The full name of GSK Pharmaceuticals is GSK Pharmaceuticals Pvt Ltd. Pharmabiz report is based on the list of company names provided by the Mahrashtra FDA.